Physician profile
Carrie R Soder
NPI 1538164926
$2,170.41
in general payments reported to CMS, 2019-2025
28 companies · $416 in 2025
The $416 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $187 · 2021: $348 · 2022: $585 · 2023: $172 · 2024: $277 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.60 |
| Education | $128.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $600.95 | 2019-2025 | Ubrelvy, Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $263.20 | 2022-2025 | |
| Therapeuticsmd, INC. | $160.94 | 2019-2022 | |
| Intuitive Surgical, INC. | $128.00 | 2025 | |
| Agile Therapeutics, INC. | $118.31 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.60 | 2019-2025 | |
| Astellas Pharma US INC | $107.97 | 2022-2025 | Veozah |
| Daiichi Sankyo INC. | $97.75 | 2020-2022 | |
| Exeltis, USA INC. | $81.45 | 2019-2025 | Slynd |
| Organon LLC | $55.03 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $54.70 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $54.25 | 2021-2024 | Aptima |
| Exact Sciences Corporation | $37.48 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $35.60 | 2024 | |
| Coopersurgical, INC. | $31.84 | 2024 | Paragard T 380a |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $30.00 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pfizer INC. | $26.87 | 2022 | |
| Evofem Biosciences, INC. | $25.80 | 2021 | |
| Allergan, INC. | $22.73 | 2019-2020 | |
| Alydia Health | $17.06 | 2021 | |
| Convatec INC. | $16.94 | 2023 | |
| Millicent US INC | $16.86 | 2025 | Intrarosa |
| Myovant Sciences INC. | $15.84 | 2021 | |
| Gynesonics, INC. | $14.25 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic INC | $12.50 | 2021 | |
| Minerva Surgical, INC | $12.39 | 2022 | |
| Merck Sharp & Dohme LLC | $12.02 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Soder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.